Home › Funds › Eagle Health Investments LP › UTHR
Eagle Health Investments LP position in UTHR
UNITED THERAPEUTICS CORP DEL · Health Care
Eagle Health Investments LP reported holding 79,678 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q3 2026 13F filing — a position valued at US$43.2M, representing 7.78% of its reported portfolio and ranking #4 among its reported holdings. Eagle Health Investments LP has disclosed UTHR holdings in 7 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Eagle Health Investments LP's UTHR position evolved
Eagle Health Investments LP first disclosed a stake in UTHR in Q3 2023 at 170,838 shares (US$38.6M). The position peaked in Q2 2024 at 167,499 shares, worth US$53.4M. Across 7 filings, Eagle Health Investments LP increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 79,678 shares valued at US$43.2M. Notable position changes include a 68% trim in Q3 2024 (shares fell 2% over the following quarter), a 60% trim in Q4 2024 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 170.84K | $38.59M | New |
| Q4 2023 | 170.84K | $37.57M | Hold |
| Q1 2024 | 179.50K | $41.23M | Add |
| Q2 2024 | 167.50K | $53.36M | Reduce |
| Q3 2024 | 54.10K | $19.39M | Reduce |
| Q4 2024 | 21.80K | $7.69M | Reduce |
| Q3 2026 | 79.68K | $43.18M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About UTHR and 13F data
UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 38 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$908.2M), ASSETMARK, INC (US$325.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UTHR
- Avoro Capital Advisors LLC 2.78M sh · $1.51B · Q2 2026
- Renaissance Technologies 1.68M sh · $908.15M · Q3 2026
- ASSETMARK, INC 600.17K sh · $325.23M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 457.00K sh · $247.62M · Q2 2026
- Vestal Point Capital, LP 435.00K sh · $235.70M · Q2 2026
- Eversept Partners, LP 287.67K sh · $155.87M · Q2 2026
More on Eagle Health Investments LP
FAQ
How long has Eagle Health Investments LP held UTHR?
Eagle Health Investments LP has disclosed UTHR holdings in 7 of the last 13 reported quarters, going back to Q3 2023.
What is Eagle Health Investments LP's current position in UTHR?
As of Q3 2026, Eagle Health Investments LP holds 79.68K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $43.18M, representing 7.78% of its reported portfolio and ranking #4.
Has Eagle Health Investments LP been buying or selling UTHR?
In the latest 13F filing (Q3 2026), Eagle Health Investments LP newly opened its position in UTHR. The position peaked in Q2 2024 at 167.50K shares.
Which other funds hold UTHR?
Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.